PDUFA III Authorizes FDA To Alert Doctors Of Failed Phase IV Commitments
This article was originally published in The Tan Sheet
Executive Summary
FDA will have the authority to require that manufacturers inform doctors of a failure to complete Phase IV commitments under the Prescription Drug User Fee Act reauthorization